Scilex Holding Company (SCLX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Scilex Holding Company’s subsidiary, Scilex Pharma, settled its lawsuit with two OTC lidocaine patch manufacturers over false advertising and unfair competition claims. The legal dispute, which was rooted in allegations under the Lanham Act and California state laws, was resolved through confidential agreements on January 26 and February 2, 2024. This development is particularly noteworthy for stakeholders in the pharmaceutical industry and could have implications for market dynamics.
For further insights into SCLX stock, check out TipRanks’ Stock Analysis page.